SHL Stock Overview
Through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Siemens Healthineers AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €49.37 |
| 52 Week High | €57.78 |
| 52 Week Low | €47.37 |
| Beta | 0.73 |
| 11 Month Change | -5.93% |
| 3 Month Change | -3.16% |
| 1 Year Change | -1.46% |
| 33 Year Change | -25.13% |
| 5 Year Change | 10.99% |
| Change since IPO | 62.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| SHL | AT Medical Equipment | AT Market | |
|---|---|---|---|
| 7D | -4.9% | -2.4% | 0.9% |
| 1Y | -1.5% | 13.2% | 1.5% |
Return vs Industry: SHL underperformed the Austrian Medical Equipment industry which returned 13.2% over the past year.
Return vs Market: SHL underperformed the Austrian Market which returned 1.5% over the past year.
Price Volatility
| SHL volatility | |
|---|---|
| SHL Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 6.2% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in AT Market | 6.3% |
| 10% least volatile stocks in AT Market | 1.8% |
Stable Share Price: SHL has not had significant price volatility in the past 3 months compared to the Austrian market.
Volatility Over Time: SHL's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 72,300 | Bernd Montag | www.siemens-healthineers.com |
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.
Siemens Healthineers AG Fundamentals Summary
| SHL fundamental statistics | |
|---|---|
| Market cap | €55.04b |
| Earnings (TTM) | €1.94b |
| Revenue (TTM) | €22.36b |
28.3x
P/E Ratio2.5x
P/S RatioIs SHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHL income statement (TTM) | |
|---|---|
| Revenue | €22.36b |
| Cost of Revenue | €13.90b |
| Gross Profit | €8.47b |
| Other Expenses | €6.53b |
| Earnings | €1.94b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Nov 26, 2024
| Earnings per share (EPS) | 1.74 |
| Gross Margin | 37.87% |
| Net Profit Margin | 8.68% |
| Debt/Equity Ratio | 89.0% |
How did SHL perform over the long term?
See historical performance and comparison